Levosimendan increases bleeding risk after heart valve surgery: A retrospective analysis of a randomized trial

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 28, Issue 5, 2014, Pages 1238-1242

  Lahtinen, Pasi ^a   Pitkänen, Otto ^a   Musialowicz, Tadeusz ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

cardiac surgery; cardiac tamponade; heart valve surgery; levosimendan; platelet; postoperative bleeding

Indexed keywords

APROTININ; CLOPIDOGREL; LEVOSIMENDAN; PLACEBO; TRANEXAMIC ACID; WARFARIN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

AGED; ANTICOAGULANT THERAPY; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART TAMPONADE; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; RETROSPECTIVE STUDY; REVIEW; ADVERSE EFFECTS; CARDIOPULMONARY BYPASS; CHEMICALLY INDUCED; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDRAZONES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PYRIDAZINES; RETROSPECTIVE STUDIES;

EID: 84908214497     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2014.04.022     Document Type: Article

References (24)

1. H.I. Eriksson, J.R. Jalonen, and L.O. Heikkinen Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function Ann Thorac Surg 87 2009 448 454
2. A. Zangrillo, G. Biondi-Zoccai, and A. Mizzi Levosimendan reduces cardiac troponin release after cardiac surgery: A meta-analysis of randomized controlled studies J Cardiothorac Vasc Anesth 23 2009 474 478
3. R.W. Harrison, V. Hasselblad, and R.H. Mehta Effect of levosimendan on survival and adverse events after cardiac surgery. A meta-analysis J Cardiothorac Vasc Anesth 27 2013 1224 1232
4. L. Tritapepe, V. De Santis, and D. Vitale Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery Br J Anaesth 102 2009 198 204
5. H. Haikala, J. Kaivola, and E. Nissinen Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan J Mol Cell Cardiol 27 1995 1859 1866
6. P. Pollesello, M. Ovaska, and J. Kaivola Binding of a new Ca2+sensitizer, levosimendan, to recombinant human cardiac troponin C: A molecular modelling, fluorescent probe, and proton nuclear magnetic resonance study J Biol Chem 269 1994 28584 28590
7. H. Yokoshiki, Y. Katsube, and M. Sunagawa Levosimendan, a novel Ca2+sensitizer, activates the glibenclamide-sensitive K+channel in rat arterial myocytes Eur J Pharmacol 333 1997 249 259
8. K. Kaptan, K. Erinc, and A. Ifran Levosimendan has an inhibitory effect on platelet function Am J Hematol 83 2008 46 49
9. N. Ambrus, J. Szolnoky, and P. Pollesello Prolonged antispasmodic effect in isolated radial artery graft and pronounced platelet inhibition induced by the inodilator drug levosimendan Basic Clin Pharmacol Toxicol 110 2012 269 274
10. P. Lahtinen, O. Pitkänen, and P. Pölönen Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial Crit Care Med 39 2011 2263 2270
11. World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research involving human subjects. Available at: http://www.wma.net/e/policy/b3.htm. Accessed June 1, 2011
12. J. Fassl, P. Matt, and Eckstein Transfusion of allogeneic blood products in proximal aortic surgery with circulatory arrest: Effect of thromboelastometry-guided transfusion management J Cardiothorac Vasc Anesth 27 2013 1181 1188
13. K. Karkouti, D.N. Wijeysundera, and T.M. Yau The independent association of massive blood loss with mortality in cardiac surgery Transfusion 44 2004 1453 1462
14. C.G. Koch, L. Li, and A.I. Duncan Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting Crit Care Med 34 2006 1608 1616
15. C.G. Koch, L. Li, and A.I. Duncan Transfusion in coronary artery bypass grafting is associated with reduced long-term survival Ann Thorac Surg 81 2006 1650 1657
16. G.J. Murphy, B.C. Reeves, and C.A. Rogers Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery Circulation 116 2007 2544 2552
17. B.C. Reeves, and G.J. Murphy Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery Curr Opin Anaesthesiol 21 2008 669 673
18. M. Ranucci, S. Aronson, and W. Dietrich Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice? J Thorac Cardiovasc Surg 142 2011 249e1 249e32
19. K. Görlinger, D. Dirkmann, and A.A. Hanke Potential value of transfusion protocols in cardiac surgery Curr Opin Anesthesiol 26 2013 230 243
20. M. Kivikko, S. Antila, and J. Eha Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure Int J Clin Pharmacol Therap 40 2002 465 471
21. S. Antila, A. Jarvinen, and T. Honkanen Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin Eur J Clin Pharmacol 56 2000 705 710
22. J. Kawasaki, N. Katori, and T. Taketomi The effects of vasoactive agents, platelet agonists and anticoagulation on thrombelastography Acta Anaesthesiol Scand 51 2007 1237 1244
23. M. Kivikko, S. Antila, and J. Eha Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure J Clin Pharmacol 42 2002 43 51
24. J.A. Quin, M.P. Tauriainen, and L.M. Huber Predictors of pericardial effusion after orthotopic heart transplantation J Thorac Cardiovasc Surg 124 2002 979 983